We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Inverness Medical Acquires Viva Diagnostika

By HospiMedica staff writers
Posted on 22 Jun 2004
In a move that will provide the company with a new European distribution network, Inverness Medical Innovations, Inc. (Waltham, MA, USA), has acquired Viva Diagnostika (Cologne, Germany).

Viva Diagnostika is a distributor of professional diagnostic products in Germany and has established a distribution network for its existing diagnostic products, including the product lines acquired from Abbott Laboratories (Abbot Park, IL, USA) in 2003, as well as it own range of cardiac products in development.

Inverness Medical Innovations is a developer of advanced diagnostic devices with a focus on women's health, cardiology, and infectious disease. The company is a leading supplier of pregnancy and fertility/ovulation tests and rapid point-of-care diagnostics. The acquisition will give the company an established distribution network for its products in Germany, which is expected to be the largest market in Europe for various cardiac markers for which Inverness plans to introduce diagnostic products.




Related Links:
Inverness
Viva Diagnostika

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics

Latest Industry News

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
22 Jun 2004  |   Industry

Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
22 Jun 2004  |   Industry

New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
22 Jun 2004  |   Industry